SEC Company Response from TuHURA Biosciences, (HURA) — May 14, 2015
TuHURA Biosciences, Inc./NV (HURA) (CIK 0001498382)
Date: May 14, 2015 · CIK: 0001498382 · Accession: 0001013762-15-000492
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-203357
Letter
Re: DelMar Pharmaceuticals, Inc. (the “Company”)
May 14, 2015
Securities and Exchange Commission
100 F. Street, NE
Washington, D.C. 20549
Registration Statement on Form S-1
File No. 333-203357
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence via EDGAR on May 12, 2015, in which we, Maxim Group LLC and Roth Capital Partners, LLC, as joint book running managers and representative of the underwriters of the Company’s proposed public offering, joined the Company’s request for acceleration of the effective date of the above-referenced Registration Statement for Thursday, May 14, 2015, at 4:00 p.m. Eastern Time. The Company Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
MAXIM GROUP LLC
Show Raw Text
CORRESP
1
filename1.htm
May 14, 2015
Securities and Exchange Commission
100 F. Street, NE
Washington, D.C. 20549
Re: DelMar Pharmaceuticals, Inc. (the “Company”)
Registration Statement on Form S-1
File No. 333-203357
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence via EDGAR
on May 12, 2015, in which we, Maxim Group LLC and Roth Capital Partners, LLC, as joint book running managers and representative
of the underwriters of the Company’s proposed public offering, joined the Company’s request for acceleration of the
effective date of the above-referenced Registration Statement for Thursday, May 14, 2015, at 4:00 p.m. Eastern Time. The Company
Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw
our request for acceleration of the effective date.
Very truly yours,
MAXIM GROUP LLC
/s/ Clifford A. Teller
_______________________________
Name: Clifford A. Teller
Title: Executive Managing Director,
Head of Investment
Banking
ROTH CAPITAL PARTNERS, LLC
/s/ Aaron M. Gurewitz
_______________________________
Name: Aaron M. Gurewitz
Title: Head of Equity Capital Markets
2